Impel PharmaceuticalsIMPL

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Mr. Adrian Adams

$5.8M

Market Cap • 15/12/2023

2008

(há 16 anos)
Fundação

2021

(3 years ago)
IPO

NASDAQ

Listagem
Flag of US

Seattle

Sede • Washington

160

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

IMPLSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-33%

1 dia

12/12/2023

-41%

1 semana

08/12/2023

-14%

1 mês

15/11/2023

-93%

1 ano

15/12/2022

10 anos

Histórico